[go: up one dir, main page]

BR9811478A - Composições de polìmero-ácido tânico para a liberação controlada de agentes farmacêuticos particularmente na cavidade oral - Google Patents

Composições de polìmero-ácido tânico para a liberação controlada de agentes farmacêuticos particularmente na cavidade oral

Info

Publication number
BR9811478A
BR9811478A BR9811478-6A BR9811478A BR9811478A BR 9811478 A BR9811478 A BR 9811478A BR 9811478 A BR9811478 A BR 9811478A BR 9811478 A BR9811478 A BR 9811478A
Authority
BR
Brazil
Prior art keywords
pharmaceutical agents
oral cavity
tannic acid
controlled release
polymer
Prior art date
Application number
BR9811478-6A
Other languages
English (en)
Inventor
E Itzhak Lerner
Vered Rosenberger
Moshe Flashner
Original Assignee
Perio Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Perio Prod Ltd filed Critical Perio Prod Ltd
Publication of BR9811478A publication Critical patent/BR9811478A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"COMPOSIçõES DE POLìMERO-áCIDO TâNICO PARA A LIBERAçãO CONTROLADA DE AGENTES FARMACêUTICOS PARTICULARMENTE NA CAVIDADE ORAL" A presente invenção está orientada para composições de liberação controlada ou sustentada de agentes farmacêuticos ou outros. Os componentes essenciais nas composições da presente invenção incluem um ou mais polímeros e ácido tânico ou tanino. A liberação de agentes farmacêuticos ou outros agentes é por um período de tempo predeterminado e a uma concentração predeterminada. O campo de ação do agente é tópico, local ou sistêmico. Os polímeros são celulósicos ou proteináceos.
BR9811478-6A 1997-07-23 1998-07-22 Composições de polìmero-ácido tânico para a liberação controlada de agentes farmacêuticos particularmente na cavidade oral BR9811478A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89912197A 1997-07-23 1997-07-23
PCT/US1998/015096 WO1999004764A1 (en) 1997-07-23 1998-07-22 Tannic acid-polymer compositions for controlled release of pharmaceutical agents, particularly in the oral cavity

Publications (1)

Publication Number Publication Date
BR9811478A true BR9811478A (pt) 2000-08-15

Family

ID=25410514

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9811478-6A BR9811478A (pt) 1997-07-23 1998-07-22 Composições de polìmero-ácido tânico para a liberação controlada de agentes farmacêuticos particularmente na cavidade oral

Country Status (10)

Country Link
EP (1) EP1003483A1 (pt)
JP (1) JP2001510788A (pt)
KR (1) KR20010021911A (pt)
AU (1) AU8578498A (pt)
BR (1) BR9811478A (pt)
CA (1) CA2296654A1 (pt)
HU (1) HUP0002490A2 (pt)
IL (1) IL134151A0 (pt)
NO (1) NO20000284L (pt)
WO (1) WO1999004764A1 (pt)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7674480B2 (en) 2000-06-23 2010-03-09 Teva Pharmaceutical Industries Ltd. Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
WO2002000213A1 (en) * 2000-06-23 2002-01-03 Teva Pharmaceutical Industries Ltd. Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
US6476006B2 (en) 2000-06-23 2002-11-05 Teva Pharmaceutical Industries, Ltd. Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates
US6881420B2 (en) 2000-06-23 2005-04-19 Teva Pharmaceutical Industries Ltd. Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferation
ATE369184T1 (de) * 2000-09-01 2007-08-15 Cognis Ip Man Gmbh Mund- und zahnpflegemittel
JP4820024B2 (ja) * 2001-01-10 2011-11-24 昭和薬品化工株式会社 局所麻酔用組成物
JP5089840B2 (ja) * 2001-09-25 2012-12-05 救急薬品工業株式会社 ニコチン含有フィルム製剤
WO2003039465A2 (en) * 2001-11-05 2003-05-15 Orahealth Corporation Treating canker sores with patches to speed healing and relieve pain
CA2518329C (en) * 2003-03-12 2015-11-24 Epitome Pharmaceuticals Limited Rapidly absorbing lipophilic skin compositions and uses therefor
US20040185009A1 (en) * 2003-03-19 2004-09-23 Dexcel Pharma Technologies Ltd. Composition and device for treating periodontal diseases
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
JP4931596B2 (ja) 2003-11-07 2012-05-16 ユーエス スモークレス タバコ カンパニー リミテッド ライアビリティ カンパニー タバコ組成物
WO2005048965A2 (en) * 2003-11-13 2005-06-02 Wm. Wrigley Jr. Company Method and composition for breath freshening
EP1750683B1 (en) 2004-04-23 2013-01-09 Amgen Inc. Sustained release formulations
WO2007118653A2 (de) * 2006-04-11 2007-10-25 Koko Kosmetikvertrieb Gmbh & Co. Kg Nanopartikel, enthaltend nicotin und/oder cotinin, dispersionen und die verwendung derselben
US8642088B2 (en) 2009-09-04 2014-02-04 Wisconsin Alumni Research Foundation Tannin-chitosan composites
KR101307367B1 (ko) * 2010-09-14 2013-09-25 주식회사 이노테라피 탄닌, 폴리에틸렌글리콜 및 물, 저급 알코올 또는 이들의 혼합물을 포함하는 접착제 조성물
US8865198B2 (en) 2010-10-25 2014-10-21 Dexcel Pharma Technologies Ltd. Method for treating a periodontal disease
FR2972327B1 (fr) * 2011-03-11 2017-08-11 Laboratoires Le Stum Composition nutraceutique mucoadhesive comprenant une association d'antioxydants
GB2496654A (en) * 2011-11-18 2013-05-22 Reckitt & Colman Overseas Self-assembling peptides
US20130158132A1 (en) * 2011-12-19 2013-06-20 Aida Salatinjants Formulation Solution Adapted To Prolong Plasma Times Of Drugs In Mammals Including Humans
WO2015167257A1 (ko) * 2014-04-29 2015-11-05 포항공과대학교 산학협력단 구강 도포용 조성물 및 그 제조 방법
RU2606589C2 (ru) * 2015-02-16 2017-01-10 Александр Александрович Кролевец Способ получения нанокапсул танина
US10532046B2 (en) * 2015-12-03 2020-01-14 Niconovum Usa, Inc. Multi-phase delivery compositions and products incorporating such compositions
CN114364373A (zh) * 2019-08-16 2022-04-15 Amd制药有限公司 粘附性药物递送微粒以及包含该粘附性药物递送微粒的产品
US12234578B2 (en) 2020-01-29 2025-02-25 Wisconsin Alumni Research Foundation Tannin composite fibers
US12303564B2 (en) 2021-03-19 2025-05-20 Wisconsin Alumni Research Foundation Composite chitosan-tannin-active agent compositions and methods of making and using same
CN115477920A (zh) * 2021-06-15 2022-12-16 西南大学 一种单宁酸基水下粘合剂制备方法及制品
KR102836840B1 (ko) 2022-04-13 2025-07-21 경북대학교 산학협력단 치아 수복을 위한 약물 서방성 자가 치유 코팅층 형성용 조성물 및 이의 제조방법
CN117322671A (zh) * 2023-11-01 2024-01-02 东莞市吉纯生物技术有限公司 一种烟碱脂质体及其制备方法与电子雾化液
WO2025183490A1 (ko) * 2024-02-29 2025-09-04 서울대학교 산학협력단 점막 백신 조성물과 그의 사용
CN119488503B (zh) * 2024-11-14 2025-06-27 沈阳盛京生物细胞研发中心有限公司 一种纳米型外泌体胶囊及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB104609A (en) * 1916-06-05 1917-03-15 Monneron & Guye A Method of Manufacturing a Medicinal Aluminium Preparation.
GB918754A (en) * 1959-08-14 1963-02-20 Armour & Co Improvements in or relating to corticotrophin preparations
GB2036750B (en) * 1978-11-23 1983-05-05 Payne M Tannin complexes
JPS5846011A (ja) * 1981-09-14 1983-03-17 Kao Corp 毛髪処理剤
JPH01166763A (ja) * 1987-12-22 1989-06-30 Nitta Gelatin Inc 医科用および歯科用硬化性材料
WO1989010745A1 (en) * 1988-05-02 1989-11-16 Pomerantz, Edwin Compositions and in situ methods for forming films on body tissue
JPH04114655A (ja) * 1990-09-03 1992-04-15 Shinonaga Kasei Kk 医療用硬化組成物
JPH04312522A (ja) * 1991-04-08 1992-11-04 Yoshiaki Kawashima 徐放性錠剤の製造方法
JP3496727B2 (ja) * 1993-12-27 2004-02-16 救急薬品工業株式会社 製剤用基剤
JPH08319232A (ja) * 1995-03-22 1996-12-03 Takeda Chem Ind Ltd 粉粒状組成物
JP2885668B2 (ja) * 1995-09-29 1999-04-26 沢井製薬株式会社 テプレノン製剤

Also Published As

Publication number Publication date
WO1999004764A1 (en) 1999-02-04
CA2296654A1 (en) 1999-02-04
AU8578498A (en) 1999-02-16
KR20010021911A (ko) 2001-03-15
NO20000284L (no) 2000-03-22
HUP0002490A2 (hu) 2000-12-28
JP2001510788A (ja) 2001-08-07
EP1003483A1 (en) 2000-05-31
NO20000284D0 (no) 2000-01-20
IL134151A0 (en) 2001-04-30

Similar Documents

Publication Publication Date Title
BR9811478A (pt) Composições de polìmero-ácido tânico para a liberação controlada de agentes farmacêuticos particularmente na cavidade oral
BR9807383A (pt) Formulação farmacêutica que compreende amoxicilina e clavulanato
BR0007147A (pt) Composição de tensìdio contendo tensìdio gemini e co-anfifila, sua preparação e aplicação
BR9406363A (pt) Composiçao farmacêutica processo para a preparaçao da mesma uso da mesma e processo para o tratamento de doenças relacionadas com o ácido gástrico
KR930016091A (ko) 거의 수불용성인 약제의 고체 분산액을 제조하는 방법
BRPI9908182B8 (pt) composições de proteína de matriz para cura de feridas
BR0316310A (pt) Composições farmacêuticas tendo um veìculo modificado
BR9910826A (pt) Composição de modelagem para xampu
BR9713866A (pt) Composição farmacéutica
BR9812018A (pt) Composições farmacêuticas de meloxicam com solubilidade e biodisponibilidade melhoradas
BR9909565A (pt) Derivados bicìclicos do ácido hidroxâmico
TR200302105T4 (tr) Siklosporin, hiyalüronik asit ve polisorbat içeren göz formülasyonları.
ES2190075T3 (es) Formulaciones farmaceuticas solidas que contienen una mezcla fisica de sulfoalquil-eter-ciclodextrina y un agente terapeutico.
BR9806236A (pt) Utilização de pelo menos um derivado de aminofenol, composição cosmética e/ou dermatológica, derivados de aminofenol e processo cosmético de despigmenlos ou dos cabelos
BRPI0113286B8 (pt) pirazóis substituídos e composição farmacêutica compreendendo os mesmos.
PT1028707E (pt) Formulacoes oftalmicas de libertacao controlada contendo medicamentos soluveis em agua
FR2784294B1 (fr) Composition cosmetique et/ou dermatologique renfermant au moins un extrait de murier, au moins un extrait de scutellaire et au moins un derive d'acide salicylique
BR9801652A (pt) Resorcinil-triazinas
FR2779648B1 (fr) Composition cosmetique ou pharmaceutique se presentant sous forme de solide et pouvant etre deformable
BR0111257A (pt) Formulação, e, uso de uma formulação
BR0015416A (pt) Composições contendo derivados do ácido hidroxieicosa tetraenóico e métodos de uso no tratamento de distúrbios de olhos secos
BR9914514A (pt) Agentes para gomagem de papel aperfeiçoados e processos para fabricação dos agentes e gomagem de papel
ES2168457T3 (es) Composiciones farmaceuticas que comprenden una superoxido dismutasa.
BR9913589A (pt) Composição, e, processo cosmético para reduzir ardência ou irritação induzidas pela aplicação tópica de uma composição
BR9904613A (pt) Utilização de uma goma de silicone, composição tópica e utilização de uma composição

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]